Proactive Investors - Run By Investors For Investors

Instem's 'never been stronger' says CEO Phil Reason

Phil Reason, chief executive of Instem Plc (LON:INS), caught up with Proactive's Andrew Scott while in London to meet with some of the firm's customers.

Reason touched on their recently won two-year SEND (Standard for the Exchange of Nonclinical Data) outsourced services contract plus gave a quick run through of second-half trading.

He says the big priorities for them in 2018 include capitalising on the new regulation for SEND and continuing their focus on increasing recurring revenues.

 
Meet Alliance Pharma plc, IXICO PLC, Benchmark Holdings PLC, Clinigen Group PLC and Shield Therapeutics PLC at our event, London , 24 January 2019. Register here »
View full INS profile View Profile

Instem Plc Timeline

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use